The latest edition of the Provider's Digest, HCPLive's monthly newsletter spotlighting regulatory decisions and pipeline news, is now live! In our July 2024 recap, we spotlight 9 FDA decisions, 6 submissions or new designations, and 5 topline data announcements. Be sure to subscribe for a recap of the therapies, companies, and individuals moving the needle in healthcare during the past month, delivered on the first Saturday of each new month! #FDANews #Healthcare #Medicine
HCPLive
Media Production
Cranbury, NJ 3,247 followers
Comprehensive clinical news that provide clinicians with up-to-date specialty and disease-specific information.
About us
HCPLive provides health care professionals with up-to-date specialty and disease-specific news, clinical information, and other resources to help provide better care to patients. On HCPLive.com, you will find in-depth conference coverage and information about upcoming meetings, perspective on regulatory news, and multimedia content featuring key opinion leaders. Get all the latest news on individual medical conditions in our "condition centers": • Cardiology • Endocrinology • Gastroenterology • Ophthalmology • Neurology • Pain Management • Pediatrics • Primary Care • Psychiatry • Rheumatology • Urology
- Website
-
http://www.HCPLive.com
External link for HCPLive
- Industry
- Media Production
- Company size
- 2-10 employees
- Headquarters
- Cranbury, NJ
- Type
- Privately Held
- Founded
- 1957
- Specialties
- Managed Care, primary care, family medicine, Healthcare news, Internal Medicine, Medicine, Medical News, FDA News, and Cardiology
Locations
-
Primary
2 Clarke Drive
Suite 100
Cranbury, NJ 08512, US
Employees at HCPLive
Updates
-
Check out this interview Naim Alkhouri, MD, FAASLD, of Arizona Liver Health, where he discusses the benefit of Agile 3 and Agile 4 scoring for the noninvasive assessment of #MASLD fibrosis and cirrhosis. Full interview: https://lnkd.in/enh66p-m #Hepatology
-
New #DiabetesDialogue: Hear from Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES and Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCES as they break down the announced pricing for the first 10 agents included in the Inflation Reduction Act price negotiations. Learn more: https://lnkd.in/eFBBPM_w #Diabetes #Healthcares
-
Earlier today, Liquidia Corporation announced the US FDA had granted tentative approval to treprostinil inhalation powder for treatment of adult patients with pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). Learn more: https://lnkd.in/gmykbmpa #Pulmonology #Cardiology
-
-
We’d love to hear from you. Join our in-home testing study today! Find out if you qualify: https://bit.ly/4d74wpi
-
-
Ravulizumab for paroxysmal nocturnal hemoglobinuria (PNH) led to patient-reported outcome scores similar to the healthy US population in the 32-week REVEAL study. In the study, David Dingli from Mayo Clinic and colleagues identified improvements in activity and quality of life scores after tracking daily activity via a wearable in patients with #PNH. Read more here: #Hematology
-
-
Sunday Spotlight 🌟: A multi-part discussion, filmed immediately following the seladelpar (Livdelzi; Gilead Sciences) decision, examined recent advances in the management of primary biliary cholangitis (PBC). The series featured expert perspectives from Nancy Reau, Palak Trivedi, and Gideon Hirschfield discussing these evolutions in PBC care and their implications for disease management. Watch the 6-part series here: https://lnkd.in/ehAH6buj #Hepatology
-
Izokibep (Affibody AB/ ACELYRIN, INC.) successfully achieved its primary and secondary endpoints in the treatment of individuals with hidradenitis suppurativa (HS), according to recently announced Phase 3 trial data. Read more on the findings, including quotes from Nikolai Brun and others, here: https://lnkd.in/evrHxSs5 #Dermatology #Acne
-
-
Lebrikizumab has been shown to offer promising relief for patients with atopic dermatitis, with improvements in both itch and sleep disturbances sustained up to 52 weeks. Learn more about these Phase 3 data with insight from investigator Raj Chovatiya, MD, PhD, MSCI: https://lnkd.in/eEjsPST3 #AtopicDermatitis #Dermatology #ClinicalTrials
-
Don’t miss the latest episode of our mini-docuseries #CrisisPoint titled "Psychiatry at a Crossroad Following FDA Decision on MDMA-Assisted Therapy." Hear reactions from experts (Casey A. Paleos, MD, Jerry Rosenbaum) and a trial participant (Cristina Pearse) on the #FDA’s decision to issue a Complete Response Letter (CRL) to Lykos Therapeutics MDMA-assisted therapy. Watch here: https://lnkd.in/eqwrY5fr